IDEAYA Biosciences GAAP EPS of $1.33, revenue of $207.83M
Source: SeekingAlpha
2025-11-04 06:24:04 ET
More on IDEAYA Biosciences
- IDEAYA Biosciences, Inc. (IDYA) Presents at 22nd International Congress - Slideshow
- IDEAYA Biosciences, Inc. (IDYA) Presents at ESMO Congress 2025 - Slideshow
- IDEAYA Biosciences, Inc. (IDYA) 10-Year Anniversary R&D Day (Transcript)
- Ideaya Biosciences gets coverage initiation at Barclays and Citizens
- IDEAYA Biosciences and Servier in-pact to develop eye cancer treatment
Read the full article on Seeking Alpha
For further details see:
IDEAYA Biosciences GAAP EPS of $1.33, revenue of $207.83M
IDEAYA Biosciences Inc.
NASDAQ: IDYA
IDYA Trading
-1.52% G/L:
$32.48 Last:
170,945 Volume:
$33.22 Open:
IDYA Latest News
March 09, 2026 06:00:00 am
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE892, a Potential Best-In-Class PRMT5 Inhibitor for MTAP-Deleted Solid Tumors, and Provides MTAP and CDKN2A Pipeline Update
February 25, 2026 06:00:00 am
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE034, a Potential First-In-Class B7H3/PTK7 Bispecific TOP1 ADC
February 23, 2026 06:00:00 am
IDEAYA Biosciences Announces Appointment of Dr. Theodora (Theo) Ross, M.D., Ph.D., as Chief Development Officer
IDYA Stock Data
$2,916,661,394
85,474,748
1.71%
105
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
